Cargando…
Multiplatform molecular test performance in indeterminate thyroid nodules
BACKGROUND: Approximately 25% of thyroid nodule fine‐needle aspirates (FNAs) have cytology that is indeterminate for malignant disease. Accurate risk stratification of these FNAs with ancillary testing would reduce unnecessary thyroid surgery. METHODS: We evaluated the performance of an ancillary mu...
Autores principales: | Lupo, Mark A., Walts, Ann E., Sistrunk, J. Woody, Giordano, Thomas J., Sadow, Peter M., Massoll, Nicole, Campbell, Ryan, Jackson, Sara A., Toney, Nicole, Narick, Christina M., Kumar, Gyanendra, Mireskandari, Alidad, Finkelstein, Sydney D., Bose, Shikha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754490/ https://www.ncbi.nlm.nih.gov/pubmed/32767735 http://dx.doi.org/10.1002/dc.24564 |
Ejemplares similares
-
A Retrospective Evaluation of the Diagnostic Performance of an Interdependent Pairwise MicroRNA Expression Analysis with a Mutation Panel in Indeterminate Thyroid Nodules
por: Finkelstein, Sydney D., et al.
Publicado: (2022) -
Incremental utility of expanded mutation panel when used in combination with microRNA classification in indeterminate thyroid nodules
por: Jackson, Sara, et al.
Publicado: (2019) -
Analytical and clinical validation of pairwise microRNA expression analysis to identify medullary thyroid cancer in thyroid fine‐needle aspiration samples
por: Ciarletto, Andrea M., et al.
Publicado: (2020) -
SUN-LB24 Clinical Performance of Multiplatform Mutation Panel MicroRNA Risk Classifier in Indeterminate Thyroid Nodules
por: Sistrunk, J Woody, et al.
Publicado: (2020) -
Utility of microdissected cytology smears for molecular analysis of thyroid malignancy
por: Kumar, Gyanendra, et al.
Publicado: (2018)